Document is current

Any future updates will be listed below

Real-world outcomes of sacituzumab govitecan in patients with pretreated triple-negative breast cancer and brain metastases: data from CEBCC-102 study

Crossref DOI link: https://doi.org/10.1007/s11060-025-05394-2

Published Online: 2026-01-14

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark